Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 189

1.

A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation.

Nin T, Sairaku A, Yoshida Y, Kamiya H, Tatematsu Y, Nanasato M, Inden Y, Hirayama H, Murohara T.

Pacing Clin Electrophysiol. 2013 Feb;36(2):172-9. doi: 10.1111/pace.12036. Epub 2012 Nov 4.

PMID:
23121681
[PubMed - indexed for MEDLINE]
2.

Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.

Kaiser DW, Streur MM, Nagarakanti R, Whalen SP, Ellis CR.

J Interv Card Electrophysiol. 2013 Sep;37(3):241-7. doi: 10.1007/s10840-013-9793-7. Epub 2013 Apr 28.

PMID:
23625091
[PubMed - indexed for MEDLINE]
3.

Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.

Lakkireddy D, Reddy YM, Di Biase L, Vanga SR, Santangeli P, Swarup V, Pimentel R, Mansour MC, D'Avila A, Sanchez JE, Burkhardt JD, Chalhoub F, Mohanty P, Coffey J, Shaik N, Monir G, Reddy VY, Ruskin J, Natale A.

J Am Coll Cardiol. 2012 Mar 27;59(13):1168-74. doi: 10.1016/j.jacc.2011.12.014. Epub 2012 Feb 1.

PMID:
22305113
[PubMed - indexed for MEDLINE]
Free Article
4.

Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation.

Bassiouny M, Saliba W, Rickard J, Shao M, Sey A, Diab M, Martin DO, Hussein A, Khoury M, Abi-Saleh B, Alam S, Sengupta J, Borek PP, Baranowski B, Niebauer M, Callahan T, Varma N, Chung M, Tchou PJ, Kanj M, Dresing T, Lindsay BD, Wazni O.

Circ Arrhythm Electrophysiol. 2013 Jun;6(3):460-6. doi: 10.1161/CIRCEP.113.000320. Epub 2013 Apr 3. Erratum in: Circ Arrhythm Electrophysiol. 2013 Oct;6(5):e79.

PMID:
23553523
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation.

Maddox W, Kay GN, Yamada T, Osorio J, Doppalapudi H, Plumb VJ, Gunter A, McElderry HT.

J Cardiovasc Electrophysiol. 2013 Aug;24(8):861-5. doi: 10.1111/jce.12143. Epub 2013 Apr 11.

PMID:
23577951
[PubMed - indexed for MEDLINE]
6.

Efficacy and safety of periprocedural dabigatran in patients undergoing catheter ablation of atrial fibrillation.

Kaseno K, Naito S, Nakamura K, Sakamoto T, Sasaki T, Tsukada N, Hayano M, Nishiuchi S, Fuke E, Miki Y, Nakamura K, Yamashita E, Kumagai K, Oshima S, Tada H.

Circ J. 2012;76(10):2337-42. Epub 2012 Jun 30.

PMID:
22785434
[PubMed - indexed for MEDLINE]
Free Article
7.

Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation.

Haines DE, Mead-Salley M, Salazar M, Marchlinski FE, Zado E, Calkins H, Yarmohammadi H, Nademanee K, Amnueypol M, Skanes AC, Saklani P.

J Interv Card Electrophysiol. 2013 Sep;37(3):233-9. doi: 10.1007/s10840-013-9800-z. Epub 2013 Jun 6.

PMID:
23740224
[PubMed - indexed for MEDLINE]
8.

Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation.

Kim JS, She F, Jongnarangsin K, Chugh A, Latchamsetty R, Ghanbari H, Crawford T, Suwanagool A, Sinno M, Carrigan T, Kennedy R, Saint-Phard W, Yokokawa M, Good E, Bogun F, Pelosi F Jr, Morady F, Oral H.

Heart Rhythm. 2013 Apr;10(4):483-9. doi: 10.1016/j.hrthm.2012.12.011. Epub 2012 Dec 11.

PMID:
23237911
[PubMed - indexed for MEDLINE]
9.

A comparison of bleeding complications post-ablation between warfarin and dabigatran.

Snipelisky D, Kauffman C, Prussak K, Johns G, Venkatachalam K, Kusumoto F.

J Interv Card Electrophysiol. 2012 Oct;35(1):29-33. doi: 10.1007/s10840-012-9708-z. Epub 2012 Aug 7.

PMID:
22869389
[PubMed - indexed for MEDLINE]
10.

Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies.

Steinberg BA, Hasselblad V, Atwater BD, Bahnson TD, Washam JB, Alexander JH, Daubert JP, Piccini JP.

J Interv Card Electrophysiol. 2013 Sep;37(3):213-21. doi: 10.1007/s10840-013-9813-7. Epub 2013 Jul 24.

PMID:
23881249
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Safety and efficacy of dabigatran compared with warfarin for patients undergoing radiofrequency catheter ablation of atrial fibrillation: a meta-analysis.

Shurrab M, Morillo CA, Schulman S, Kansal N, Danon A, Newman D, Lashevsky I, Healey JS, Crystal E.

Can J Cardiol. 2013 Oct;29(10):1203-10. doi: 10.1016/j.cjca.2013.07.005. Epub 2013 Aug 29. Review.

PMID:
23993352
[PubMed - indexed for MEDLINE]
12.

Dabigatran in the peri-procedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stay.

Imamura K, Yoshida A, Takei A, Fukuzawa K, Kiuchi K, Takami K, Takami M, Itoh M, Fujiwara R, Suzuki A, Nakanishi T, Yamashita S, Matsumoto A, Hirata K.

J Interv Card Electrophysiol. 2013 Sep;37(3):223-31. doi: 10.1007/s10840-013-9801-y. Epub 2013 Apr 14.

PMID:
23585240
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin.

Konduru SV, Cheema AA, Jones P, Li Y, Ramza B, Wimmer AP.

J Interv Card Electrophysiol. 2012 Dec;35(3):277-84; discussion 284. doi: 10.1007/s10840-012-9719-9. Epub 2012 Sep 27.

PMID:
23015216
[PubMed - indexed for MEDLINE]
14.

A head-to-head comparison of periprocedural coagulability under anticoagulation with rivaroxaban versus dabigatran in patients undergoing ablation of atrial fibrillation.

Sairaku A, Yoshida Y, Ando M, Hirayama H, Nakano Y, Kihara Y.

Clin Drug Investig. 2013 Nov;33(11):847-53. doi: 10.1007/s40261-013-0134-5.

PMID:
24081373
[PubMed - indexed for MEDLINE]
15.

The incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation: comparison of warfarin and dabigatran.

Ichiki H, Oketani N, Ishida S, Iriki Y, Okui H, Maenosono R, Namino F, Ninomiya Y, Miyata M, Hamasaki S, Tei C.

Pacing Clin Electrophysiol. 2013 Nov;36(11):1328-35. doi: 10.1111/pace.12195. Epub 2013 Aug 16.

PMID:
23952291
[PubMed - indexed for MEDLINE]
16.

Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis.

ProvidĂȘncia R, Albenque JP, Combes S, Bouzeman A, Casteigt B, Combes N, Narayanan K, Marijon E, Boveda S.

Heart. 2014 Feb;100(4):324-35. doi: 10.1136/heartjnl-2013-304386. Epub 2013 Jul 22. Review.

PMID:
23878175
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Usefulness of dabigatran etexilate as periprocedural anticoagulation therapy for atrial fibrillation ablation.

Yamaji H, Murakami T, Hina K, Higashiya S, Kawamura H, Murakami M, Kamikawa S, Hirohata S, Kusachi S.

Clin Drug Investig. 2013 Jun;33(6):409-18. doi: 10.1007/s40261-013-0081-1.

PMID:
23572324
[PubMed - indexed for MEDLINE]
18.

The use of dabigatran immediately after atrial fibrillation ablation.

Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA.

J Cardiovasc Electrophysiol. 2012 Mar;23(3):264-8. doi: 10.1111/j.1540-8167.2011.02175.x. Epub 2011 Sep 28.

PMID:
21955008
[PubMed - indexed for MEDLINE]
19.

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.

Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, Yang S, Alings M, Kaatz S, Hohnloser SH, Diener HC, Franzosi MG, Huber K, Reilly P, Varrone J, Yusuf S.

Circulation. 2011 May 31;123(21):2363-72. doi: 10.1161/CIRCULATIONAHA.110.004747. Epub 2011 May 16.

PMID:
21576658
[PubMed - indexed for MEDLINE]
Free Article
20.

Periprocedural dabigatran in atrial fibrillation ablation: a new kid on the block.

Pelargonio G, Perna F.

J Cardiovasc Electrophysiol. 2013 Aug;24(8):866-8. doi: 10.1111/jce.12168. Epub 2013 May 6. No abstract available.

PMID:
23647979
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk